Syneos Health and uMotif Partner to Deliver Patient-centriceClinical Platform
SYNHDelisted Stock | USD 42.31 0.07 0.17% |
Under 61% of Syneos Health's investor base is looking to short. The analysis of current outlook of investing in Syneos Health suggests that many traders are alarmed regarding Syneos Health's prospects. Syneos Health's investing sentiment shows overall attitude of investors towards Syneos Health.
Syneos |
Integrated eCOA ePRO Solution Taps Companys Decentralized Capabilities and Technology ExpertiseMORRISVILLE, N.C., June 26, 2023 Syneos Health , a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with uMotif, a clinical trial technology company putting the patient at the center of research. The collaboration will help accelerate clinical trials and bring new therapies to patients faster through a more e
Read at finance.yahoo.com
Syneos Health Fundamental Analysis
We analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Syneos Health is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Syneos Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Syneos Health stock to make a market-neutral strategy. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics with similar companies.
Peers
Syneos Health Related Equities
MEDP | Medpace Holdings | 1.65 | ||||
SHC | Sotera Health | 1.52 | ||||
MTD | Mettler Toledo | 0.50 | ||||
CRL | Charles River | 0.37 | ||||
MYGN | Myriad Genetics | 0.07 | ||||
IQV | IQVIA Holdings | 0.35 | ||||
QGEN | Qiagen NV | 0.43 | ||||
RDNT | RadNet | 0.58 | ||||
LH | Laboratory | 0.64 | ||||
NEOG | Neogen | 1.81 | ||||
ICLR | ICON PLC | 2.38 | ||||
ACRS | Aclaris Therapeutics | 7.63 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stocks Directory Find actively traded stocks across global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |